US68622P1093

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

June 06, 2025 16:30 ET  | Source: ORIC Pharmaceuticals SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, June 06, 2025 (GLOBE…

1 month ago